Gurbel PA - Search Results

1

Influence of platelet reactivity and inflammation on peri-procedural myonecrosis in East Asian patients undergoing elective percutaneous coronary intervention.

Jeong YH, Tantry US, Min JH, Park Y, Navarese EP, Koh JS, Park JR, Hwang SJ, Kho EH, Bliden KP, Kwak CH, Hwang JY, Kim S, Gurbel PA. Jeong YH, et al. Among authors: gurbel pa. Int J Cardiol. 2013 Sep 20;168(1):427-35. doi: 10.1016/j.ijcard.2012.09.132. Epub 2012 Oct 12. Int J Cardiol. 2013. PMID: 23068571

2

Durability of platelet inhibition by clopidogrel.

Gurbel PA, Bliden KP. Gurbel PA, et al. Am J Cardiol. 2003 May 1;91(9):1123-5. doi: 10.1016/s0002-9149(03)00163-2. Am J Cardiol. 2003. PMID: 12714161 Clinical Trial. No abstract available.

3

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.

Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Gurbel PA, et al. Circulation. 2003 Jun 17;107(23):2908-13. doi: 10.1161/01.CIR.0000072771.11429.83. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796140 Clinical Trial.

4

Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).

Gurbel PA, Galbut B, Bliden KP, Bahr RD, Roe MT, Serebruany VL, Gibler WB, Christenson RH, Ohman EM; EARLY Platelet Substudy. Gurbel PA, et al. J Thromb Thrombolysis. 2002 Dec;14(3):213-9. doi: 10.1023/a:1025048726396. J Thromb Thrombolysis. 2002. PMID: 12913401 Clinical Trial.

5

Platelet activation after stenting with heparin-coated versus noncoated stents.

Gurbel PA, Bliden KP. Gurbel PA, et al. Am Heart J. 2003 Oct;146(4):E10. doi: 10.1016/S0002-8703(03)00317-X. Am Heart J. 2003. PMID: 14564333 Clinical Trial.

6

A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activity.

Gurbel PA, Bliden KP. Gurbel PA, et al. Platelets. 2003 Nov-Dec;14(7-8):481-3. doi: 10.1080/02697450310001632588. Platelets. 2003. PMID: 14713517 Free article. No abstract available.

7

The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.

Gurbel PA, Bliden KP. Gurbel PA, et al. Thromb Res. 2003;112(1-2):9-12. doi: 10.1016/j.thromres.2003.09.029. Thromb Res. 2003. PMID: 15013266 Clinical Trial.

8

Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis.

Gurbel PA, Samara WM, Bliden KP. Gurbel PA, et al. Platelets. 2004 Mar;15(2):95-9. doi: 10.1080/09537100310001646950. Platelets. 2004. PMID: 15154601 Free article. Clinical Trial.

9

Platelet activation in myocardial ischemic syndromes.

Gurbel PA, Bliden KP, Hayes KM, Tantry U. Gurbel PA, et al. Expert Rev Cardiovasc Ther. 2004 Jul;2(4):535-45. doi: 10.1586/14779072.2.4.535. Expert Rev Cardiovasc Ther. 2004. PMID: 15225113 Review.

10

The difference between clopidogrel responsiveness and posttreatment platelet reactivity.

Samara WM, Bliden KP, Tantry US, Gurbel PA. Samara WM, et al. Among authors: gurbel pa. Thromb Res. 2005;115(1-2):89-94. doi: 10.1016/j.thromres.2004.07.002. Thromb Res. 2005. PMID: 15567458 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters